comprehensive -WSS

comprehensive

author：Wikipedia 2025-09-30 16:26:30 - browse：6

Boston Scientific headquarters -- Health coverage from STAT — Boston Scientific is growing its urology portfolio with the Axonics acquisition. Steven Senne/AP

Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion.

It’s the first billion-dollar medical device deal of 2024 — a rare occurrence in 2023, which saw just a handful of medtech acquisitions reaching the billion threshold. Boston Scientific said it expects to close the deal in the first half of this year. Axonics’ stock increased by 20% in light of the news; Boston Scientific’s dropped slightly.

Boston Scientific has acquired companies across all medtech sectors in the past year. The device maker bought Apollo Endosurgery, a company selling surgical tools to combat obesity, for $615 million in 2023. In September of 2023, Boston Scientific bought pain relief company Relievant for $850 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Live blog: Hearing on CRISPR

WSS

Inari Medical to buy amputation prevention company LimFlow

After Sarepta trial failure, Duchenne families brace for more debate

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Woodcock on FDA’s accelerated approval and her next chapter

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Woodcock on FDA’s accelerated approval and her next chapter

Wikipedia

comprehensive

focus

What does generative AI mean for health care? We asked experts

Medicare drug price negotiation’s day in court

The high cost of giving birth even with insurance

Kidney transplant patients stopped immunosuppressants in trial

The high cost of giving birth even with insurance

After Sarepta trial failure, Duchenne families brace for more debate

In Memoriam: Notable people who died in 2023

General Catalyst, Summa Health deal will turn on physician buy

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Medicare proceeds with plan to claw back hospital funds

knowledge

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Vertex non

Do digital therapeutics have a future in medicine?

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Woodcock on FDA’s accelerated approval and her next chapter

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

hotspot

explore

focus

hotspot